INFLIXIMAB (IFX) IN MODERATE TO SEVERE ULCERATIVE COLITIS (UC): COMPARISON BETWEEN SCHEDULED TREATMENT STRATEGY AND BRIDGE STRATEGY

被引：0
|
作者：
Sambuelli, Alicia M.
Bellicoso, Maricel I.
Goncalves, Silvina A.
Negreira, Silvia
Huernos, Sergio P.
Chavero, Paula
Carraro, Cecilia
Tirado, Pablo
Cabanne, Ana
Gil, Anibal H.
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)31579-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1944
引用
收藏
页码：S402 / S402
页数：1
相关论文
共 50 条
  • [41] The use of infliximab for treatment of hospitalized patients with acute severe ulcerative colitis
    Bressler, B.
    Law, J. K.
    Sheraisher, N. Al Nahdo
    Atkinson, K.
    Byrne, M. F.
    Chung, H. V.
    Fishman, M.
    Partovi, N.
    Pearson, D.
    Penner, R.
    Enns, R. A.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 22 (11): : 937 - 940
  • [42] 'Treat to Target' in Mild to Moderate Ulcerative Colitis: Evidence to Support this Strategy
    Dal Buono, Arianna
    Roda, Giulia
    Argollo, Marjorie
    Paridaens, Kristine
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    CURRENT DRUG TARGETS, 2021, 22 (01) : 117 - 125
  • [43] Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab
    Freeman, Hugh J.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2013, 9 : 451 - 456
  • [44] Economic evaluation of adacolumn apheresis for the treatment of patients with moderate to severe Crohn's disease (CD)/ulcerative colitis (UC)
    Persson, U
    Borg, S
    Hjelmgren, J
    Ljung, T
    Riis, L
    Ostergaard, L
    Thomsen, O
    Munkholm, P
    VALUE IN HEALTH, 2005, 8 (06) : A120 - A121
  • [45] Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis
    D'Amico, Ferdinando
    Magro, Fernando
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (05): : 835 - 844
  • [46] An evaluation of risankizumab for the treatment of moderate-to-severe ulcerative colitis
    Johnson, Amanda M.
    Loftus Jr, Edward V.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (12) : 1317 - 1327
  • [47] PREDICT UC: OPTIMISING INFLIXIMAB INDUCTION THERAPY FOR ACUTE SEVERE ULCERATIVE COLITIS - A RANDOMISED CONTROLLED TRIAL
    Choy, Matthew C.
    Li, Christopher F.
    Suen, Wai
    Con, Danny
    Boyd, Kristy
    Pena, Raquel
    Burrell, Kathryn
    Rosella, Ourania
    Proud, David
    Brouwer, Richard G.
    Gorelik, Alexandra
    Liew, Danny
    Connell, William
    Wright, Emily K.
    Taylor, Kirstin M.
    Pudipeddi, Aviv
    Sawers, Michelle
    Christensen, Britt
    Ng, Watson
    Begun, Jakob
    Radford-Smith, Graham L.
    Garg, Mayur
    Martin, Neal
    Van Langenberg, Daniel R.
    Ding, Nik S.
    Beswick, Lauren
    Leong, Rupert
    Sparrow, Miles
    De Cruz, Peter
    GASTROENTEROLOGY, 2024, 166 (05) : S215 - S215
  • [48] PREDICT UC: Optimising Infliximab Induction therapy for Acute Severe Ulcerative Colitis - A Randomised Controlled Trial
    Choy, M.
    Suen, C. F. D. Li Wai
    Con, D.
    Boyd, K.
    Pena, R.
    Burrell, K.
    Rosella, O.
    Proud, D.
    Brouwer, R.
    Gorelik, A.
    Liew, D.
    Connell, W.
    Wright, E.
    Taylor, K.
    Pudipeddi, A.
    Sawers, M.
    Christensen, B.
    Ng, W.
    Begun, J.
    Radford-Smith, G.
    Garg, M.
    Martin, N.
    Van Langenberg, D. R.
    Ding, N. S.
    Beswick, L.
    Leong, R. W.
    Sparrow, M. P.
    De Cruz, P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1600 - I1600
  • [49] Psychometric Properties of the Ulcerative Colitis Electronic Diary (UC e-Diary) in Adult Patients with Moderate-to-Severe Ulcerative Colitis
    Tahir, Muna J.
    Shahraz, Saeid
    Wang, Song
    Nagy, Peter
    Kamble, Pravin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S427 - S427
  • [50] Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis
    Danese, Silvio
    D'Amico, Ferdinando
    Bonovas, Stefanos
    Peyrin-Biroulet, Laurent
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (10) : 2106 - 2112
12345